The design, synthesis and structure-activity relationships of 1-aryl-4-aminoalkylisoquinolines: A novel series of CRF-1 receptor antagonists

被引：18

作者：

Yoon, Taeyoung ^{[1
]}

De Lombaert, Stephane ^{[1
]}

Brodbeck, Robbin ^{[1
]}

Gulianello, Michael ^{[1
]}

Chandrasekhar, Jayaraman ^{[1
]}

Horvath, Raymond F. ^{[1
]}

Ge, Ping ^{[1
]}

Kershaw, Mark T. ^{[1
]}

Krause, James E. ^{[1
]}

Kehne, John ^{[1
]}

Hoffman, Diane ^{[1
]}

Doller, Dario ^{[1
]}

Hodgetts, Kevin J. ^{[1
]}

机构：

[1] Neurogen Corp, Branford, CT 06405 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 03期

关键词：

CRF-1 receptor antagonist; 1-aryl-4-aminoalkylisoquinoline; depression; anxiety;

D O I：

10.1016/j.bmcl.2007.12.050

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The design, synthesis and structure-activity relationships of a novel series of CRF-1 receptor antagonist, the 1-aryl-4-alkylaminoisoquinolines, is described. The effects of substitution on the aromatic ring, the amino group and the isoquinoline core on CRF-1 receptor binding were investigated. (C) 2007 Elsevier Ltd. All rights reserved.

引用

下载

页码：891 / 896

页数：6

共 50 条

[1] Design, synthesis and structure-activity relationships of 5-alkylaminolquinolines as a novel series of CRF1 receptor antagonists
Takeda, Kunitoshi
Terauchi, Taro
Shin, Kogyoku
Ino, Mitsuhiro
Shibata, Hisashi
Yonaga, Masahiro
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) : 4756 - 4761
[2] Synthesis and structure-activity relationships of carboxylated chalcones: A novel series of CysLT(1) (LTD(4)) receptor antagonists
Zwaagstra, ME
Timmerman, H
Tamura, M
Tohma, T
Wada, Y
Onogi, K
Zhang, MQ
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (07) : 1075 - 1089
[3] Design, synthesis, and structure-activity relationships of a series of 2-Ar-8-methyl-5-alkylaminoquinolines as novel CRF1 receptor antagonists
Takeda, Kunitoshi
Terauchi, Taro
Hashizume, Minako
Shin, Kogyoku
Ino, Mitsuhiro
Shibata, Hisashi
Yonaga, Masahiro
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (17) : 5372 - 5378
[4] 2-Arylpyrimidines: Novel CRF-1 receptor antagonists
Yoon, Taeyoung
De Lombaert, Stephane
Brodbeck, Robbin
Gulianello, Michael
Krause, James E.
Hutchison, Alan
Horvath, Raymond F.
Ge, Ping
Kehne, John
Hoffman, Diane
Chandrasekhar, Jayaraman
Doller, Dario
Hodgetts, Kevin J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (16) : 4486 - 4490
[5] Novel γ-aminobutyric acid ρ1 receptor antagonists;: Synthesis, pharmacological activity and structure-activity relationships
Kumar, Rohan J.
Chebib, Mary
Hibbs, David E.
Kim, Hye-Lim
Johnston, Graham A. R.
Salam, Noeris K.
Hanrahan, Jane R.
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) : 3825 - 3840
[6] Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines:: A novel series of potent and selective α1a-adrenergic receptor antagonists
Kuo, GH
Prouty, C
Murray, WV
Pulito, V
Jolliffe, L
Cheung, P
Varga, S
Evangelisto, M
Wang, J
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (11) : 2183 - 2195
[7] 2-Aryl-3,6-dialkyl-5-dialkylaminopyrimidin-4-ones as novel CRF-1 receptor antagonists
Hodgetts, KJ
Yoon, T
Huang, JH
Gulianello, M
Kieltyka, A
Primus, R
Brodbeck, R
De Lombaert, S
Doller, D
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (15) : 2497 - 2500
[8] Design, synthesis, and structure-activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists
Yoshida, Yu
Terauchi, Taro
Naoe, Yoshimitsu
Kazuta, Yuji
Ozaki, Fumihiro
Beuckmann, Carsten T.
Nakagawa, Makoto
Suzuki, Michiyuki
Kushida, Ikuo
Takenaka, Osamu
Ueno, Takashi
Yonaga, Masahiro
BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (21) : 6071 - 6088
[9] Synthesis and structure-activity relationships in a series of ethenesulfonamide derivatives, a novel class of endothelin receptor antagonists
Harada, H
Kazami, J
Watanuki, S
Tsuzuki, R
Sudoh, K
Fujimori, A
Tokunaga, T
Tanaka, A
Tsukamoto, S
Yanagisawa, I
CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (12) : 1593 - 1603
[10] Structure-activity relationships of a series of 1-substituted-4-methylbenzimidazole neuropeptide Y-1 receptor antagonists
Zimmerman, DM
Cantrell, BE
Smith, ECR
Nixon, JA
Bruns, RF
Gitter, B
Hipskind, PA
Ornstein, PL
Zarrinmayeh, H
Britton, TC
Schober, DA
Gehlert, DR
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (05) : 473 - 476

← 1 2 3 4 5 →